Natural history of meningiomas: a serial volumetric analysis of 240 tumors

Pascal ThomannDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Pascal Thomann in
Current site
Google Scholar
PubMed
Close
 MD
,
Levin HäniDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Levin Häni in
Current site
Google Scholar
PubMed
Close
 MD
,
Sonja VulcuDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Sonja Vulcu in
Current site
Google Scholar
PubMed
Close
 MD
,
Alessa SchützDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Alessa Schütz in
Current site
Google Scholar
PubMed
Close
 MD
,
Maximilian FroschDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;
Institute of Neuropathology, Medical Center—University of Freiburg, Germany;

Search for other papers by Maximilian Frosch in
Current site
Google Scholar
PubMed
Close
 MD
,
Christopher Marvin JesseDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Christopher Marvin Jesse in
Current site
Google Scholar
PubMed
Close
 MD
,
Marwan El-KoussyDepartment of Radiology and Neuroradiology, Hospital of Emmental, Burgdorf, Switzerland; and

Search for other papers by Marwan El-Koussy in
Current site
Google Scholar
PubMed
Close
 MD
,
Nicole SöllDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Nicole Söll in
Current site
Google Scholar
PubMed
Close
,
Arsany HakimInstitute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Switzerland

Search for other papers by Arsany Hakim in
Current site
Google Scholar
PubMed
Close
 MD
,
Andreas RaabeDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Andreas Raabe in
Current site
Google Scholar
PubMed
Close
 MD
, and
Philippe SchuchtDepartment of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Switzerland;

Search for other papers by Philippe Schucht in
Current site
Google Scholar
PubMed
Close
 MD
View More View Less
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $525.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
USD  $45.00
USD  $525.00
USD  $624.00
Print or Print + Online Sign in

OBJECTIVE

The management of asymptomatic intracranial meningiomas is controversial. Through the assessment of growth predictors, the authors aimed to create the basis for practicable clinical pathways for the management of these tumors.

METHODS

The authors volumetrically analyzed meningiomas radiologically diagnosed at their institution between 2003 and 2015. The primary endpoint was growth of tumor volume. The authors used significant variables from the multivariable regression model to construct a decision tree based on the exhaustive Chi-Square Automatic Interaction Detection (CHAID) algorithm.

RESULTS

Of 240 meningiomas, 159 (66.3%) demonstrated growth during a mean observation period of 46.9 months. On multivariable logistic regression analysis, older age (OR 0.979 [95% CI 0.958–1.000], p = 0.048) and presence of calcification (OR 0.442 [95% CI 0.224–0.872], p = 0.019) had a negative predictive value for tumor growth, while T2-signal iso-/hyperintensity (OR 4.415 [95% CI 2.056–9.479], p < 0.001) had a positive predictive value. A decision tree model yielded three growth risk groups based on T2 signal intensity and presence of calcifications. The median tumor volume doubling time (Td) was 185.7 months in the low-risk, 100.1 months in the intermediate-risk, and 51.7 months in the high-risk group (p < 0.001). Whereas 0% of meningiomas in the low- and intermediate-risk groups had a Td of ≤ 12 months, the percentage was 8.9% in the high-risk group (p = 0.021).

CONCLUSIONS

Most meningiomas demonstrated growth during follow-up. The absence of calcifications and iso-/hyperintensity on T2-weighted imaging offer a practical way of stratifying meningiomas as low, intermediate, or high risk. Small tumors in the low- or intermediate-risk categories can be monitored with longer follow-up intervals.

ABBREVIATIONS

CHAID = Chi-Square Automatic Interaction Detection; PFS = progression-free survival; RGR = relative annual growth rate; Td = tumor volume doubling time.

Supplementary Materials

    • Supplementary Figure and Tables (PDF 890 KB)
  • Collapse
  • Expand

Figure from Kim et al. (pp 1601–1609).

  • 1

    Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(2)(suppl 2):ii1ii56.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):18211828.

  • 3

    Bos D, Poels MMF, Adams HHH, et al. Prevalence, clinical management, and natural course of incidental findings on brain MR images: the population-based Rotterdam Scan Study. Radiology. 2016;281(2):507515.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Nakasu S, Hirano A, Shimura T, Llena JF. Incidental meningiomas in autopsy study. Surg Neurol. 1987;27(4):319322.

  • 5

    Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery. 2003;53(1):6271.

  • 6

    Hashiba T, Hashimoto N, Izumoto S, et al. Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg. 2009;110(4):675684.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Oya S, Kim SH, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg. 2011;114(5):12501256.

  • 8

    Hashimoto N, Rabo CS, Okita Y, et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg. 2012;116(3):574580.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Jadid KD, Feychting M, Höijer J, Hylin S, Kihlström L, Mathiesen T. Long-term follow-up of incidentally discovered meningiomas. Acta Neurochir (Wien). 2015;157(2):225230.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Lee EJ, Kim JH, Park ES, et al. A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. J Neurosurg. 2017;127(5):971980.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Ehresman JS, Mampre D, Rogers D, Olivi A, Quinones-Hinojosa A, Chaichana KL. Volumetric tumor growth rates of meningiomas involving the intracranial venous sinuses. Acta Neurochir (Wien). 2018;160(8):15311538.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Romani R, Ryan G, Benner C, Pollock J. Non-operative meningiomas: long-term follow-up of 136 patients. Acta Neurochir (Wien). 2018;160(8):15471553.

  • 13

    Islim AI, Kolamunnage-Dona R, Mohan M, et al. A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro Oncol. 2020;22(2):278289.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14:12721294.

  • 15

    Kass GV. An exploratory technique for investigating large quantities of categorical data. J R Stat Soc Ser C. 1980;29(2):119127.

  • 16

    Nakasu S, Nakasu Y. Natural history of meningiomas: review with meta-analyses. Neurol Med Chir (Tokyo). 2020;60(3):109120.

  • 17

    Behbahani M, Skeie GO, Eide GE, Hausken A, Lund-Johansen M, Skeie BS. A prospective study of the natural history of incidental meningioma—Hold your horses! Neurooncol Pract. 2019;6(6):438450.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg. 1995;83(2):222224.

  • 19

    Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry. 2000;68(1):2528.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Firsching RP, Fischer A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. J Neurosurg. 1990;73(4):545547.

  • 21

    Hirota K, Fujita T, Akagawa H, Onda H, Kasuya H. Spontaneous regression together with increased calcification of incidental meningioma. Surg Neurol Int. 2014;5:73.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Kumaria A, Ingale HA, Macarthur DC. Spontaneous regression of a large skull base meningioma: case report. Br J Neurosurg. 2020;34(2):205206.

  • 23

    Kalamarides M, Peyre M. Dramatic shrinkage with reduced vascularization of large meningiomas after cessation of progestin treatment. World Neurosurg. 2017;101:814.e7814.e10.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Kerschbaumer J, Freyschlag CF, Stockhammer G, et al. Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report. J Neurosurg. 2016;124(1):137140.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    de Almeida JPC, Petteys RJ, Sciubba DM, Gallia GL, Brem H. Regression of intracranial meningioma following intratumoral hemorrhage. J Clin Neurosci. 2009;16(9):12461249.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Zeng L, Liang P, Jiao J, Chen J, Lei T. Will an asymptomatic meningioma grow or not grow? A meta-analysis. J Neurol Surg A Cent Eur Neurosurg. 2015;76(5):341347.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Rubinstein AB, Shalit MN, Cohen ML, Zandbank U, Reichenthal E. Radiation-induced cerebral meningioma: a recognizable entity. J Neurosurg. 1984;61(5):966971.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Al-Mefty O, Topsakal C, Pravdenkova S, Sawyer JR, Harrison MJ. Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics. J Neurosurg. 2004;100(6):10021013.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Choudhary A, Pradhan S, Huda MF, Mohanty S, Kumar M. Radiation induced meningioma with a short latent period following high dose cranial irradiation - case report and literature review. J Neurooncol. 2006;77(1):7377.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    Soffer D, Pittaluga S, Feiner M, Beller AJ. Intracranial meningiomas following low-dose irradiation to the head. J Neurosurg. 1983;59(6):10481053.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Godlewski B, Drummond KJ, Kaye AH. Radiation-induced meningiomas after high-dose cranial irradiation. J Clin Neurosci. 2012;19(12):16271635.

  • 32

    Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg. 2002;97(5):10781082.

  • 33

    Seliger C, Meier CR, Becker C, et al. Metabolic syndrome in relation to risk of meningioma. Oncotarget. 2017;8(2):22842292.

  • 34

    Seliger C, Meier CR, Becker C, et al. Diabetes, use of metformin, and the risk of meningioma. PLoS One. 2017;12(7):e0181089.

  • 35

    Muskens IS, Wu AH, Porcel J, et al. Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the multiethnic cohort. Neuro Oncol. 2019;21(4):498507.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    Dresser L, Yuen CA, Wilmington A, et al. Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Sci Rep. 2020;10(1):17960.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Demicheli R, Foroni R, Ingrosso A, Pratesi G, Soranzo C, Tortoreto M. An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res. 1989;49(23):65436546.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 1481 1462 38
Full Text Views 415 409 30
PDF Downloads 579 571 41
EPUB Downloads 0 0 0